Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis

Mucorales are fungal pathogens that cause mucormycosis, a lethal angioinvasive disease. Previously, we demonstrated that , the most common cause of mucormycosis, invades endothelial cells by binding of its CotH proteins to the host receptor GRP78. Loss of CotH3 renders the fungus noninvasive and att...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2019-06, Vol.5 (6), p.eaaw1327-eaaw1327
Hauptverfasser: Gebremariam, Teclegiorgis, Alkhazraji, Sondus, Soliman, Sameh S M, Gu, Yiyou, Jeon, Heewon H, Zhang, Lina, French, Samuel W, Stevens, David A, Edwards, Jr, John E, Filler, Scott G, Uppuluri, Priya, Ibrahim, Ashraf S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Mucorales are fungal pathogens that cause mucormycosis, a lethal angioinvasive disease. Previously, we demonstrated that , the most common cause of mucormycosis, invades endothelial cells by binding of its CotH proteins to the host receptor GRP78. Loss of CotH3 renders the fungus noninvasive and attenuates virulence in mice. Here, we demonstrate that polyclonal antibodies raised against peptides of CotH3 protected diabetic ketoacidotic (DKA) and neutropenic mice from mucormycosis compared to mice treated with control preimmune serum. Passive immunization with anti-CotH3 antibodies enhanced neutrophil inlfux and triggered Fc receptor-mediated enhanced opsonophagocytosis killing of . Monoclonal antibodies raised against the CotH3 peptide also protected immunosuppressed mice from mucormycosis caused by and other Mucorales and acted synergistically with antifungal drugs in protecting DKA mice from infection. These data identify anti-CotH3 antibodies as a promising adjunctive immunotherapeutic option against a deadly disease that often poses a therapeutic challenge.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.aaw1327